() Flunixin Injection-S (flunixin meglumine injection) | Norbrook

Flunixin Injection-S       

(flunixin meglumine injection) 

A potent, fast-acting non-steroidal anti-inflammatory drug (NSAID) indicated for the control of pyrexia associated with swine respiratory disease (SRD). 

Target Species: Swine

Product Attributes

  • Controls fever (pyrexia) associated with SRD

  • Non-narcotic, non-steroidal analgesic

  • Anti-inflammatory and anti-pyretic activity

  • Flunixin Injection-S is administered as an intramuscular (IM) injection in swine at 2 mL per 100 lbs

  • FDA approved

  • Available in 100 mL and 250 mL multi-dose vials


CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. 



Observe label directions and withdrawal times. Not for use in breeding swine. Cyclooxygenase inhibitory NSAIDs may be associated with gastrointestinal, renal and hepatic toxicity. Concomitant use with other anti-inflammatory drugs should be avoided. See product labeling for full product information. 

  • Active Ingredient(s)

    flunixin 50 mg/mL

  • Dosage Form

    Solution for Injection 

  • Indications

    Flunixin Injection -S (flunixin meglumine injection) is indicated for the control of pyrexia associated with swine respiratory disease.

  • Dosage and Administration

    The recommended dose for swine is 2.2 mg/kg (1 mg/lb; 2 mL per 100 lbs) body weight given by a single intramuscular administration. The injection should be given only in the neck musculature with a maximum of 10 mL per site.

    Note: Intramuscular injection may cause local tissue irritation and damage. In an injection-site irritation study, the tissue damage did not resolve in all animals by Day 28 post-injection. This may result in trim loss of edible tissue at slaughter.

    Flunixin Injection-S Residue Warning

  • Storage

    Store between 2° and 30°C (36° and 86°F). Use within 60 days of first puncture. When using a draw-off spike or needle with a bore diameter larger than 16-gauge, discard any product remaining in the vial immediately after use.

© 2023 Norbrook Laboratories Limited. The Norbrook logo is a registered trademark of Norbrook Laboratories Limited.

Prefer to speak directly to a member of our team?

Norbrook®, Inc.

We are open Mon - Fri 8:00am - 5:00pm CST

Please note: Product information presented on this website is intended only as a brief summary of Norbrook products for your convenience. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information you should always consult a healthcare professional from your region or visit the local government agency website for the most up to date information. Please see our terms and conditions for further information.